Dex-Esk

DRUG2 trials

Sponsors

Peking University First Hospital

Conditions

Cognitive FunctionDexmedetomidineEsketamineOlder PatientsPerioperative Neurocognitive DisordersSurgerySurvivalTranscranial Direct Current Stimulation

Phase 4

Dexmedetomidine-esketamine and tDCS for Prevention of Neurocognitive Complications After Surgery

Not yet recruitingNCT07576517

Peking University First HospitalDexmedetomidine, Esketamine, Older Patients +3

Start: 2026-06-01End: 2030-06-01Target: 1160Updated: 2026-05-12

Long-term Follow-up of Dexmedetomidine-esketamine and tDCS for Neurocognitive Complications After Surgery

Not yet recruitingNCT07576543

Peking University First HospitalCognitive Function, Dexmedetomidine, Esketamine +4

Start: 2026-06-01End: 2031-06-01Target: 1160Updated: 2026-05-12